Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PPARGC1A contributors: mct/shn - updated : 21-06-2017
HGNC name peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
HGNC id 9237
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --low  
in breast carcinoma with poor outcome
constitutional     --low  
in type 2 diabetes
constitutional     --over  
increased muscle expression of PPARGC1A paradoxically exacerbated fat-induced insulin resistance in skeletal muscle despite an increase in mitochondrial density and mitochondrial activity
constitutional     --low  
in muscle from HD subjects (
Susceptibility
  • insulin sensitivity and non-insulin dependent diabetes (type 2) in some populations
  • obesity in middle aged women
  • Variant & Polymorphism SNP G482S polymorphism and other in insulin sensitivity, diabetes, obesity and hypertension
    Candidate gene
    Marker
    Therapy target
  • Overexpression of PGC-1 in CREB-deficient mice restored glucose homeostasis and rescued expression of gluconeogenic gene
  • SystemTypeDisorderPubmed
    neurologyneurodegenerativehuntington chorea
    activator of PPARGC1A and TFAM may be a potential therapeutic strategy in Huntington disease
    neurologyneurodegenerative 
    therapeutic agents activating PPARGC1A, PPARGC1B would be valuable for treating neurodegenerative diseases in which mitochondrial dysfunction and oxidative damage play an important pathogenic role
    cardiovascularaquired 
    beneficial role of PPARGC1A in therapies for cardiac diseases
    neurologyneurodegenerativealzheimer
    over-expression of PGC-1α could completely rescue mitochondrial biogenesis AD-causing amyloid precursor protein M17 cells
    cardiovascularaquiredheart failure
    elevating PGC-1alpha activity may have therapeutic potential in the treatment of heart failure
    neurologyneurodegenerativehuntington chorea
    PPARGC1A upstream of TFEB are important therapeutic targets in HD and potentially other neurodegenerative disorders caused by protein misfolding
    ANIMAL & CELL MODELS
  • PGC-1alpha null mice are lean and resistant to diet-induced obesity, constitutively activate gluconeogenic gene expression, and have elevated C/EBPbeta in liver
  • transverse aortic constriction in mice lacking PGC-1alpha leads to accelerated cardiac dysfunction accompanied by signs of significant clinical heart failure
  • mice lacking PGC-1alpha show abnormal diurnal rhythms of activity, body temperature and metabolic rate
  • mice with combined deficiency of PGC-1alpha and PGC-1beta died shortly after birth with small hearts, bradycardia, intermittent heart block, and a markedly reduced cardiac output
  • impaired function of PGC-1alpha plays a critical role in muscle dysfunction in Huntington's disease transgenic mice
  • expression levels of PGC-1 alpha is significantly decreased in both Alzheimer's disease hippocampal tissues and AD-causing amyloid precursor protein mutant M17 cells
  • knockdown of PGC-1 alpha could exacerbate impaired mitochondrial biogenesis and mitochondrial deficits in AD-causing amyloid precursor protein mutant M17 cells
  • mice that lack cardiac PGC-1 alpha, a powerful regulator of angiogenesis, develop profound peripartum cardiomyopathy